Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-14-032687

Director sold 300,000 shares at $2.44 ($730,500)

From the SEC's structured data for this filing

Trades in this filing

KINGSLEY ALFRED D · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2014-05-08 Sale : show line 1 in the form −300,000 $2.44 $730,500 6,288,055 D
Open-market sales · 300,000 sh · avg $2.44 · $730,500
Loading xslF345X03/doc4.xml…